SCHEMBL4907228

SCHEMBL4907228

Cc1csc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2C Q8TBX8 1/20 0.60
CSNK2A1 P68400 7/20 0.56
CSNK2A2 P19784 5/20 0.56
CSNK2B P67870 5/20 0.56
LMNA P02545 4/20 0.56
THRB P10828 1/20 0.56
PTPN5 P54829 1/20 0.56
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
KMT2A Q03164 1/20 0.55
POLB P06746 1/20 0.54
GAA P10253 1/20 0.54
PKM P14618 1/20 0.54
TP53 P04637 1/20 0.53
AURKB Q96GD4 6/20 0.53
EGFR P00533 4/20 0.53
DYRK3 O43781 2/20 0.52
MAP4K4 O95819 2/20 0.52
PIM1 P11309 2/20 0.52
CLK2 P49760 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13242729 0.84 AURKA (0.58) PIP4K2CLMNAMEN1ALDH1A1KMT2A
SCHEMBL4909670 0.80 MKNK2 (0.71) CSNK2A1CSNK2A2CSNK2BGAAAURKB
SCHEMBL4908388 0.79 PIP4K2C (0.61) PIP4K2CCSNK2A1CSNK2A2CSNK2BLMNA
SCHEMBL26786625 0.78 AURKB (0.63) AURKBEGFRMAP4K4PIM1CLK4
Hydrochloric Acid SCHEMBL810092 0.78 PIP4K2C (0.60) PIP4K2CCSNK2A1CSNK2A2CSNK2BLMNA
SCHEMBL6639881 0.75 LMNA (0.48) CSNK2A1CSNK2A2CSNK2BLMNATHRB
SCHEMBL5455292 0.74 LMNA (0.73) PIP4K2CCSNK2A1LMNAMEN1ALDH1A1
SCHEMBL13861829 0.73 KDR (0.79) CSNK2A1CSNK2A2CSNK2BLMNATHRB
SCHEMBL3799687 0.72 PIP4K2C (0.52) PIP4K2CCSNK2A1CSNK2A2CSNK2BLMNA
Hydrochloric Acid SCHEMBL8810503 0.71 AURKB (0.66) KMT2APOLBGAAAURKBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108611-A1 SUBSTITUTED THIENOPYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108611-A1 SUBSTITUTED THIENOPYRIMIDINE KINASE INHIBITORS MAP4K2, MAP3K6, MAP3K2 PIP4K2C 333/4885CSNK2A1 390/4885CSNK2A2 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.